ovalo health bpc-157 BPC-157: A Prohibited Peptide and an Unapproved Drug Found in and Wellness Products ovalo health bpc 157 Healthgevity

Tirzepatide is a dual GIP and GLP-1 receptor agonist used as an adjunct to diet and exercise for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound)496903084605990312L34-L35

Dietary counselling helps vegans and vegetarians ensure adequate B12 intake through fortified foods or supplements

BPC-157 is a synthetic 15-amino-acid peptide derived from a Body Protection Compound fragment originally identified in human gastric juice, with research interest in nitric oxide pathway activity, VEGFR2 signalling, and FAK-paxillin pathway involvement

Benefits : Reduces intestinal inflammation Promotes gut lining healing Supports healthy microbiome Reduces permeability (leaky gut) Applications : Inflammatory bowel disease (supportive) IBS with inflammation Leaky gut syndrome Post-antibiotic gut damage Protocol : 1-2mg daily oral or subcutaneous, 8-12 weeks Combines with : BPC-157 (excellent gut peptide) Injectable GHK-Cu dosing Most effective route for systemic benefits

Clinical Update 8/16/2022 Water for Dry Eye